These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 4574129

  • 21. Candida peritonitis treated with 5-fluorocytosine in a patient receiving hemodialysis.
    Phillips I, Eykyn S, MacGregor GA, Jones NF.
    Clin Nephrol; 1973; 1(4):271-2. PubMed ID: 4593451
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
    Torres-Rodríguez JM, Sabaté M, Gallach C, Carrillo A, Madrenys N.
    Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
    [Abstract] [Full Text] [Related]

  • 26. Torulopsis glabrata meningoencephalitis treated with 5-flucytosine.
    Wurzel B, Goldberg P, Caroline L, Bozza AT, Kozinn PJ.
    Ann Intern Med; 1972 Nov; 77(5):814-5. PubMed ID: 4673228
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
    Karlowsky JA, Hoban DJ, Zhanel GG, Goldstein BP.
    Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
    [Abstract] [Full Text] [Related]

  • 30. Antifungal susceptibilities of Candida species isolated from urine culture.
    Toka Özer T, Durmaz S, Yula E.
    J Infect Chemother; 2016 Sep; 22(9):629-32. PubMed ID: 27452427
    [Abstract] [Full Text] [Related]

  • 31. Flucytosine in urinary candida infections.
    Wise GJ, Wainstein S, Goldberg P, Kozinn PJ.
    Urology; 1974 Jun; 3(6):708-11. PubMed ID: 4600251
    [No Abstract] [Full Text] [Related]

  • 32. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM, Reviákina V, Dolande M, Selgrad S.
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [Abstract] [Full Text] [Related]

  • 33. Primary resistance to flucytosine among clinical isolates of Candida spp.
    Barchiesi F, Arzeni D, Caselli F, Scalise G.
    J Antimicrob Chemother; 2000 Mar; 45(3):408-9. PubMed ID: 10702571
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
    Ozhak-Baysan B, Ogunc D, Colak D, Ongut G, Donmez L, Vural T, Gunseren F.
    Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses.
    Fass RJ, Perkins RL.
    Ann Intern Med; 1971 Apr; 74(4):535-9. PubMed ID: 5551162
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.